We are live on ! Find out more
BGM

Burkehill Global Management Portfolio holdings

AUM $2.02B
1-Year Est. Return 85.32%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+85.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.52B
AUM Growth
-$242M
Cap. Flow
-$232M
Cap. Flow %
-15.26%
Top 10 Hldgs %
29.41%
Holding
211
New
70
Increased
9
Reduced
6
Closed
53

Top Buys

Rank Stock Value
1
ITT icon
ITT
ITT
+$62.7M
2
EL icon
Estee Lauder
EL
+$43.7M
3
ROL icon
Rollins
ROL
+$42.6M
4
MDLN
Medline Inc
MDLN
+$40.9M
5
O icon
Realty Income
O
+$34.7M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$89.8M
2
BRO icon
Brown & Brown
BRO
+$70.3M
3
LTM
LATAM Airlines Group S.A.
LTM
+$43M
4
VRSN icon
VeriSign
VRSN
+$42.1M
5
FOX icon
Fox Class B
FOX
+$30.6M

Sector Composition

Rank Sector Weight
1 Industrials 22.84%
2 Healthcare 18.52%
3 Financials 14.15%
4 Consumer Discretionary 12.53%
5 Technology 11.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMMX icon
126
Immix Biopharma
IMMX
$692M
$1.54M 0.1%
+294,118
New +$1.21M
CABA icon
127
Cabaletta Bio
CABA
$455M
$1.53M 0.1%
700,000
ESPR
128
DELISTED
Esperion Therapeutics
ESPR
$1.48M 0.1%
+400,000
New +$1.29M
TNYA icon
129
Tenaya Therapeutics
TNYA
$163M
$1.42M 0.09%
+2,000,000
New +$2.72M
DFTX
130
Definium Therapeutics
DFTX
$6.12B
$1.34M 0.09%
+100,000
New +$1.24M
ASPI icon
131
ASP Isotopes
ASPI
$558M
$1.34M 0.09%
+250,000
New +$1.99M
KMTS
132
Kestra Medical Technologies
KMTS
$1.55B
$1.33M 0.09%
+50,000
New +$1.29M
MPLT
133
MapLight Therapeutics
MPLT
$552M
$1.32M 0.09%
+75,000
New +$1.26M
VERA icon
134
Vera Therapeutics
VERA
$2.36B
$1.27M 0.08%
+25,000
New +$888K
CHYM
135
Chime Financial
CHYM
$11B
$1.26M 0.08%
50,000
LXEO icon
136
Lexeo Therapeutics
LXEO
$378M
$1.24M 0.08%
+125,000
New +$1.14M
MNTN
137
MNTN Inc
MNTN
$821M
$1.19M 0.08%
100,000
RCUS icon
138
Arcus Biosciences
RCUS
$3.64B
$1.19M 0.08%
+50,000
New +$1.02M
GUTS icon
139
Fractyl Health
GUTS
$111M
$1.1M 0.07%
500,000
DEC
140
Diversified Energy Company
DEC
$980M
$1.09M 0.07%
75,000
TEM
141
Tempus AI
TEM
$9.39B
$1.05M 0.07%
17,800
-24,200
-58% -$1.89M
GEMI
142
Gemini Space Station
GEMI
$517M
$992K 0.07%
100,000
VSTM icon
143
Verastem
VSTM
$610M
$965K 0.06%
+125,000
New +$1.11M
LMRI
144
Lumexa Imaging Holdings
LMRI
$1.11B
$925K 0.06%
+50,000
New +$903K
EVMN
145
Evommune Inc
EVMN
$511M
$856K 0.06%
+50,000
New +$939K
CBIO
146
Crescent Biopharma
CBIO
$626M
$844K 0.06%
+74,000
New +$943K
OMDA
147
Omada Health Inc
OMDA
$1.41B
$789K 0.05%
50,000
ATAI icon
148
AtaiBeckley Inc
ATAI
$2.68B
$757K 0.05%
+185,000
New +$873K
INR
149
Infinity Natural Resources
INR
$243M
$737K 0.05%
50,000
CARL
150
Carlsmed
CARL
$377M
$618K 0.04%
50,000

Similar funds

Burkehill Global Management's Q4 2025 Portfolio in Review

As of Q4 2025, Burkehill Global Management held 211 positions worth $1.52B, down 14% from $1.76B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Burkehill Global Management withdrew a net $232M in Q4 2025, closing 53 positions and reducing 6 holdings. Its most notable exit was Sandisk, an estimated $89.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Burkehill Global Management opened a new position in ITT worth $60.7M.

  • Burkehill Global Management's largest Q4 2025 buy was ITT: 350,000 shares worth $60.7M.
  • Burkehill Global Management added most to SoFi Technologies in Q4 2025, an estimated $27.9M increase.
  • Burkehill Global Management's biggest Q4 2025 reduction was CoreWeave, cutting an estimated $15.2M.
  • Burkehill Global Management fully exited Sandisk in Q4 2025, selling an estimated $89.8M.
  • Burkehill Global Management's ten largest holdings make up 29% of its $1.52B portfolio in Q4 2025.
  • Burkehill Global Management opened 70 new positions and closed 53 in Q4 2025.
  • Burkehill Global Management's portfolio value fell 14% quarter-over-quarter to $1.52B.

Based on Burkehill Global Management's 13F filing for Q4 2025, filed 17 Feb 2026.